$15M funding aims to advance stem cell therapies for petsJanuary 8, 2024The financing will go toward achieving the conditional U.S. Food and Drug Administration (FDA) approval of Gallant Therapeutic’s candidate for feline chronic gingivostomatitis
SPONSORED CONTENTA Modern Approach to Parasite PreventionWith evolving parasite threats, traditional preventatives may not be enough. Discover how innovation is changing the landscape of protection. + Learn More